About Teladoc (NYSE:TDOC)
Teladoc, Inc. provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers of Fortune 1000 companies, health plans, health systems, and other entities. Teladoc, Inc. was founded in 2002 and is headquartered in Purchase, New York.
Industry, Sector and Symbol
Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
SymbolNYSE:TDOC
CUSIPN/A
Phone203-635-2002
Debt
Debt-to-Equity Ratio0.37%
Current Ratio3.87%
Quick Ratio3.87%
Price-To-Earnings
Trailing P/E Ratio-25.79
Forward P/E Ratio-31.06
P/E GrowthN/A
Sales & Book Value
Annual Sales$233.28 million
Price / Sales11.26
Cash FlowN/A
Price / CashN/A
Book Value$9.80 per share
Price / Book4.34
Profitability
EPS (Most Recent Fiscal Year)($1.65)
Net Income$-106,780,000.00
Net Margins-45.77%
Return on Equity-20.95%
Return on Assets-13.11%
Miscellaneous
Employees1,231
Outstanding Shares61,730,000
Teladoc (NYSE:TDOC) Frequently Asked Questions
What is Teladoc's stock symbol?
Teladoc trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."
How were Teladoc's earnings last quarter?
Teladoc (NYSE:TDOC) announced its quarterly earnings data on Tuesday, February, 27th. The health services provider reported ($0.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.40) by $0.10. The health services provider earned $77.14 million during the quarter, compared to the consensus estimate of $76.14 million. Teladoc had a negative net margin of 45.77% and a negative return on equity of 20.95%. View Teladoc's Earnings History.
When is Teladoc's next earnings date?
What guidance has Teladoc issued on next quarter's earnings?
Teladoc issued an update on its FY18 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of -$1.36 to -$1.41 for the period, compared to the Thomson Reuters consensus estimate of ($1.14). The company issued revenue guidance of $350 million to $360 million, compared to the consensus revenue estimate of $356.43 million.Teladoc also updated its Q1 guidance to -$0.43 to -$0.45 EPS.
What price target have analysts set for TDOC?
16 brokers have issued 12 month price objectives for Teladoc's stock. Their forecasts range from $32.00 to $50.00. On average, they expect Teladoc's stock price to reach $41.9286 in the next year. View Analyst Ratings for Teladoc.
What are Wall Street analysts saying about Teladoc stock?
Here are some recent quotes from research analysts about Teladoc stock:
- 1. Cantor Fitzgerald analysts commented, "4Q17 in line or slightly better than expected. Revenue was $77 million vs. our estimate and FactSet of consensus of $76 million. Visits grew 49%. PMPM was $0.95 vs. $0.91 in 3Q17. Gross margin declined y/y given the expected revenue shift. TDOC reported positive adjusted EBITDA of $2.4M vs FactSet $2.5M. GAAP EPS included several non-recurring/non-cash items. Overall, we believe that TDOC had a strong quarter." (2/27/2018)
- 2. According to Zacks Investment Research, "The stock of Teladoc has outperformed the industry year to date. The company is witnessing steady business growth with insurers and customers increasingly embracing telehealth. It’s organic growth initiative remains on track. With a number of acquisitions completed since its inception, the company has expanded its distribution capabilities and broadened its service offering. Also the company boasts an impressive clientele. The company has also provided strong guidance for 2017. The company has incurred significant losses in each period since its inception in 2002. Teladoc has been unable to generate cash from operations and we have doubts over its ability to do so in the coming quarters. Its high debt level has caused a spike in interest expense which has dented its operating margins." (10/18/2017)
Who are some of Teladoc's key competitors?
Some companies that are related to Teladoc include Straumann (SAUHY), William Demant (WILYY), Straumann (SAUHF), NMC Health (NMHLY), Sonic Healthcare (SHL), Aspen Pharmacare (APNHY), Alnylam Pharmaceuticals (ALNY), Eurofins Scientific (ERFSF), Jazz Pharmaceuticals (JAZZ), BioMérieux (BMXMF), BeiGene (BGNE), WellCare (WCG), bluebird bio (BLUE), STERIS (STE) and Sonic Healthcare (SKHHY).
Who are Teladoc's key executives?
Teladoc's management team includes the folowing people:
- Mr. Jason Gorevic, CEO & Director (Age 46)
- Mr. Mark J. Hirschhorn, Chief Financial Officer, Chief Operating Officer and Exec. VP (Age 53)
- Mr. Michael King, Chief Sales Officer (Age 55)
- Mr. Peter A. McClennen, Pres (Age 49)
- Dr. George Byron Brooks BS EE, M.D., Co-Founder
When did Teladoc IPO?
(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.
Has Teladoc been receiving favorable news coverage?
Media coverage about TDOC stock has been trending somewhat positive this week, according to Accern. Accern identifies negative and positive press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Teladoc earned a coverage optimism score of 0.08 on Accern's scale. They also assigned news headlines about the health services provider an impact score of 46.25 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
Who are Teladoc's major shareholders?
Teladoc's stock is owned by a variety of of institutional and retail investors. Top institutional investors include
TRIDENT CAPITAL MANAGEMENT-VI, L.L.C.
(5.60%). Company insiders that own Teladoc stock include Adam C Vandervoort, Andrew Turitz, James K Outland, Jason N Gorevic, Lp Chp III, Mark Hirschhorn, Michael Goldstein, Michael H King, Peter A Mcclennen and Trident Capital Fund Vi Lp. View Institutional Ownership Trends for Teladoc.
How do I buy shares of Teladoc?
Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Teladoc's stock price today?
One share of TDOC stock can currently be purchased for approximately $42.55.
How big of a company is Teladoc?
Teladoc has a market capitalization of $2.64 billion and generates $233.28 million in revenue each year. The health services provider earns $-106,780,000.00 in net income (profit) each year or ($1.65) on an earnings per share basis. Teladoc employs 1,231 workers across the globe.
How can I contact Teladoc?
Teladoc's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]
MarketBeat Community Rating for Teladoc (TDOC)
MarketBeat's community ratings are surveys of what our community members think about Teladoc and other stocks. Vote "Outperform" if you believe TDOC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TDOC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Teladoc (NYSE:TDOC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
16 Wall Street analysts have issued ratings and price targets for Teladoc in the last 12 months. Their average twelve-month price target is $41.9286, suggesting that the stock has a possible downside of 1.46%. The high price target for TDOC is $50.00 and the low price target for TDOC is $32.00. There are currently 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.75 | 2.73 | 2.79 | 2.73 |
| Ratings Breakdown: | 0 Sell Rating(s)
4 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
4 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $41.9286 | $41.6154 | $39.4167 | $38.00 |
| Price Target Upside: | 1.46% downside | 3.11% downside | 14.25% upside | 14.63% upside |
Teladoc (NYSE:TDOC) Consensus Price Target History
Teladoc (NYSE:TDOC) Analyst Ratings History
Show:
(Data available from 4/24/2016 forward)
Teladoc (NYSE:TDOC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Teladoc (NYSE TDOC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 4.47%
Teladoc (NYSE TDOC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/16/2018 | Jason N Gorevic | CEO | Sell | 25,000 | $41.36 | $1,034,000.00 | 661,184 |  |
| 3/12/2018 | Jason N Gorevic | CEO | Sell | 40,000 | $43.27 | $1,730,800.00 | | |
| 3/7/2018 | Peter A. Mcclennen | President | Sell | 27,533 | $43.01 | $1,184,194.33 | | |
| 3/6/2018 | Andrew Turitz | SVP | Sell | 36,210 | $40.39 | $1,462,521.90 | 16,700 | |
| 3/5/2018 | Adam C Vandervoort | Insider | Sell | 47,123 | $39.36 | $1,854,761.28 | 19,338 | |
| 3/2/2018 | Adam C Vandervoort | Insider | Sell | 27,809 | $38.62 | $1,073,983.58 | 19,338 | |
| 3/2/2018 | Andrew Turitz | SVP | Sell | 19,245 | $39.25 | $755,366.25 | 16,700 | |
| 3/2/2018 | Michael Goldstein | Director | Sell | 66,574 | $39.72 | $2,644,319.28 | 54,325 | |
| 2/28/2018 | Mark Hirschhorn | CFO | Sell | 100,000 | $39.60 | $3,960,000.00 | 98,960 | |
| 12/4/2017 | Jason N Gorevic | CEO | Sell | 100,000 | $32.99 | $3,299,000.00 | 718,261 | |
| 12/4/2017 | Mark Hirschhorn | CFO | Sell | 30,000 | $32.99 | $989,700.00 | 5,203 | |
| 11/2/2017 | Jason N Gorevic | CEO | Sell | 20,000 | $32.10 | $642,000.00 | 838,261 | |
| 10/17/2017 | Mark Hirschhorn | VP | Sell | 35,000 | $32.84 | $1,149,400.00 | 20,887 | |
| 10/16/2017 | Mark Hirschhorn | CFO | Sell | 25,000 | $32.37 | $809,250.00 | 20,887 | |
| 10/2/2017 | Jason N Gorevic | CEO | Sell | 20,000 | $33.47 | $669,400.00 | | |
| 10/2/2017 | Mark Hirschhorn | VP | Sell | 10,000 | $34.04 | $340,400.00 | | |
| 9/22/2017 | Mark Hirschhorn | VP | Sell | 25,000 | $31.93 | $798,250.00 | 64,987 | |
| 8/7/2017 | Adam C Vandervoort | Insider | Sell | 53,806 | $30.92 | $1,663,681.52 | 33,008 | |
| 6/6/2017 | Jason N Gorevic | CEO | Sell | 19,991 | $32.89 | $657,503.99 | 831,650 | |
| 6/5/2017 | Jason N Gorevic | CEO | Sell | 13,389 | $32.89 | $440,364.21 | 831,650 | |
| 5/25/2017 | Jason N Gorevic | CEO | Sell | 5,600 | $29.57 | $165,592.00 | 823,861 | |
| 5/23/2017 | Jason N Gorevic | CEO | Sell | 14,400 | $29.57 | $425,808.00 | 822,961 | |
| 5/17/2017 | Mark Hirschhorn | VP | Sell | 100,000 | $27.70 | $2,770,000.00 | 80,887 | |
| 5/8/2017 | Jason N Gorevic | CEO | Sell | 15,000 | $23.11 | $346,650.00 | 833,261 | |
| 4/19/2017 | Mark Hirschhorn | VP | Sell | 59,100 | $25.46 | $1,504,686.00 | 180,887 | |
| 4/19/2017 | Michael H King | Insider | Sell | 5,000 | $25.75 | $128,750.00 | 61,459 | |
| 1/26/2017 | Mark Hirschhorn | VP | Sell | 900 | $20.00 | $18,000.00 | 239,987 | |
| 1/24/2017 | Jason N Gorevic | CEO | Sell | 100,000 | $15.79 | $1,579,000.00 | 926,158 | |
| 1/24/2017 | Trident Capital Fund Vi Lp | Major Shareholder | Sell | 250,000 | $15.79 | $3,947,500.00 | | |
| 1/19/2017 | Michael H King | Insider | Sell | 5,000 | $19.00 | $95,000.00 | 66,459 | |
| 1/17/2017 | Mark Hirschhorn | VP | Sell | 10,000 | $17.84 | $178,400.00 | 240,887 | |
| 1/9/2017 | Mark Hirschhorn | VP | Sell | 5,000 | $17.50 | $87,500.00 | 250,887 | |
| 12/15/2016 | Mark Hirschhorn | VP | Sell | 5,000 | $16.60 | $83,000.00 | 255,887 | |
| 12/14/2016 | Lp Chp III | Major Shareholder | Sell | 500,000 | $16.36 | $8,180,000.00 | | |
| 11/16/2016 | Mark Hirschhorn | VP | Sell | 10,000 | $17.19 | $171,900.00 | 258,387 | |
| 11/10/2016 | Mark Hirschhorn | VP | Sell | 5,000 | $17.50 | $87,500.00 | 267,687 | |
| 10/17/2016 | Mark Hirschhorn | VP | Sell | 5,000 | $15.52 | $77,600.00 | 268,387 | |
| 8/16/2016 | Jason N Gorevic | CEO | Sell | 40,000 | $17.92 | $716,800.00 | 967,258 | |
| 8/11/2016 | Michael H King | Insider | Sell | 25,000 | $17.20 | $430,000.00 | 91,459 | |
| 8/8/2016 | Adam C Vandervoort | Insider | Sell | 52,865 | $16.64 | $879,673.60 | 46,685 | |
| 8/2/2016 | James K Outland | Director | Sell | 10,000 | $18.00 | $180,000.00 | 49,089 | |
| 7/15/2016 | Jason N Gorevic | CEO | Sell | 5,000 | $15.45 | $77,250.00 | 932,258 | |
| 6/29/2016 | James K Outland | Director | Sell | 10,000 | $15.00 | $150,000.00 | 59,089 | |
| 6/29/2016 | Jason N Gorevic | CEO | Sell | 5,000 | $15.01 | $75,050.00 | 932,258 | |
| 3/17/2016 | Dana G Jr. Mead | Director | Buy | 10,000 | $10.65 | $106,500.00 | 90 | |
| 9/10/2015 | William H Frist | Director | Buy | 4,500 | $22.54 | $101,430.00 | 4,500 | |
(Data available from 1/1/2013 forward)
Teladoc (NYSE TDOC) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Teladoc (TDOC) and Envision Healthcare (EVHC) Head-To-Head Contrast
www.americanbankingnews.com - April 22 at 11:24 PM |
| Chardan Capital Boosts Teladoc (TDOC) Price Target to $41.00
www.americanbankingnews.com - April 20 at 8:00 PM |
| Teladoc (TDOC) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - April 19 at 10:45 AM |
| Analyzing iKang Healthcare Group (KANG) and Teladoc (TDOC)
www.americanbankingnews.com - April 19 at 5:39 AM |
 | Teladoc to Announce First Quarter 2018 Financial Results
finance.yahoo.com - April 18 at 5:55 PM |
| Jason N. Gorevic Sells 25,000 Shares of Teladoc (TDOC) Stock
www.americanbankingnews.com - April 18 at 4:10 PM |
| Teladoc (TDOC) Downgraded to Hold at BidaskClub
www.americanbankingnews.com - April 16 at 12:19 AM |
| Head-To-Head Analysis: iKang Healthcare Group (KANG) and Teladoc (TDOC)
www.americanbankingnews.com - April 14 at 7:23 PM |
| Teladoc's (TDOC) "Buy" Rating Reaffirmed at Canaccord Genuity
www.americanbankingnews.com - April 14 at 7:21 AM |
| Teladoc (TDOC) Downgraded by BidaskClub to Sell
www.americanbankingnews.com - April 13 at 3:51 PM |
| Teladoc (TDOC) Upgraded to "Hold" by BidaskClub
www.americanbankingnews.com - April 11 at 8:59 PM |
| $86.80 Million in Sales Expected for Teladoc Inc (TDOC) This Quarter
www.americanbankingnews.com - April 11 at 1:47 AM |
| Teladoc (TDOC) Cut to Sell at BidaskClub
www.americanbankingnews.com - April 10 at 12:01 PM |
| Zacks: Analysts Anticipate Teladoc Inc (TDOC) to Announce -$0.43 EPS
www.americanbankingnews.com - April 9 at 11:18 PM |
 | Teladoc Is Worth A Look
seekingalpha.com - April 6 at 5:56 PM |
| Teladoc (TDOC) Given New $46.00 Price Target at Wells Fargo
www.americanbankingnews.com - April 6 at 10:47 AM |
 | This Morning's Research Reports on Healthcare Information Services Stocks -- athenahealth, Evolent Health ...
www.prnewswire.com - April 4 at 8:01 AM |
| Teladoc (TDOC) Stock Rating Upgraded by ValuEngine
www.americanbankingnews.com - April 2 at 11:27 PM |
| Analyzing Teladoc (TDOC) & iKang Healthcare Group (KANG)
www.americanbankingnews.com - March 31 at 7:16 PM |
 | Why Is Teladoc (TDOC) Up 10.3% Since Its Last Earnings Report?
www.zacks.com - March 30 at 5:46 PM |
| Teladoc (TDOC) Rating Reiterated by KeyCorp
www.americanbankingnews.com - March 29 at 2:30 PM |
 | The Analysts Are Right About Teladoc Inc — It’s a Buy!
investorplace.com - March 29 at 10:36 AM |
| The Analysts Are Right About Teladoc Inc — It’s a Buy!
investorplace.com - March 29 at 10:19 AM |
| Teladoc Inc (TDOC) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 25 at 9:58 AM |
| Teladoc Inc (TDOC) Expected to Post Quarterly Sales of $86.84 Million
www.americanbankingnews.com - March 25 at 2:16 AM |
 | KeyBanc: 6 Reasons To Buy Teladoc - Benzinga
www.benzinga.com - March 16 at 8:01 AM |
| Teladoc (TDOC) Rating Lowered to Hold at Deutsche Bank
www.americanbankingnews.com - March 15 at 11:42 PM |
| KeyCorp Reaffirms "Overweight" Rating for Teladoc (TDOC)
www.americanbankingnews.com - March 15 at 11:42 PM |
| KeyBanc: 6 Reasons To Buy Teladoc
finance.yahoo.com - March 15 at 6:31 PM |
| Insider Selling: Teladoc Inc (TDOC) CEO Sells 40,000 Shares of Stock
www.americanbankingnews.com - March 14 at 7:11 PM |
| Teladoc to Participate in Upcoming Investor Conferences
finance.yahoo.com - March 9 at 7:10 PM |
| Teladoc Inc (TDOC) President Sells $1,184,194.33 in Stock
www.americanbankingnews.com - March 9 at 6:21 PM |
| Why Teladoc (TDOC) Stock Has More Than Doubled in a Year - Yahoo Finance
finance.yahoo.com - March 9 at 8:01 AM |
 | Why Teladoc (TDOC) Stock Has More Than Doubled in a Year - Nasdaq
www.nasdaq.com - March 8 at 8:01 AM |
| Brokerages Expect Teladoc Inc (TDOC) Will Post Quarterly Sales of $86.84 Million
www.americanbankingnews.com - March 8 at 2:54 AM |
| Why Teladoc (TDOC) Stock Has More Than Doubled in a Year
finance.yahoo.com - March 7 at 6:51 PM |
| Why Teladoc Shares Set a New Record Last Week
finance.yahoo.com - March 7 at 8:05 AM |
| Andrew Turitz Sells 36,210 Shares of Teladoc Inc (TDOC) Stock
www.americanbankingnews.com - March 6 at 9:26 PM |
| Andrew Turitz Sells 19,245 Shares of Teladoc Inc (TDOC) Stock
www.americanbankingnews.com - March 6 at 9:26 PM |
| Teladoc Inc (TDOC) Director Michael Goldstein Sells 66,574 Shares
www.americanbankingnews.com - March 6 at 6:14 PM |
| -$0.42 Earnings Per Share Expected for Teladoc Inc (TDOC) This Quarter
www.americanbankingnews.com - March 6 at 5:08 PM |
| UBS Asset Management Americas Inc. Has $13.38 Million Stake in Teladoc Inc (TDOC)
www.americanbankingnews.com - March 6 at 3:14 PM |
| Alliancebernstein L.P. Grows Stake in Teladoc Inc (TDOC)
www.americanbankingnews.com - March 6 at 4:14 AM |
| Teladoc Inc (TDOC) Insider Adam C. Vandervoort Sells 27,809 Shares
www.americanbankingnews.com - March 5 at 9:11 PM |
| Adam C. Vandervoort Sells 47,123 Shares of Teladoc Inc (TDOC) Stock
www.americanbankingnews.com - March 5 at 9:10 PM |
| Sectoral Asset Management Inc Reduces Position in Teladoc Inc (TDOC)
www.americanbankingnews.com - March 5 at 3:33 PM |
| FY2018 EPS Estimates for Teladoc Inc Raised by Cantor Fitzgerald (TDOC)
www.americanbankingnews.com - March 5 at 4:46 AM |
| Teladoc Inc Forecasted to Earn Q1 2018 Earnings of ($0.44) Per Share (TDOC)
www.americanbankingnews.com - March 5 at 1:28 AM |
| Teladoc Inc (TDOC) CFO Mark Hirschhorn Sells 100,000 Shares
www.americanbankingnews.com - March 2 at 6:22 PM |
| Deutsche Bank Raises Teladoc (TDOC) Price Target to $45.00
www.americanbankingnews.com - March 2 at 6:16 PM |
Teladoc (NYSE:TDOC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Teladoc (NYSE:TDOC) Income Statement, Balance Sheet and Cash Flow Statement
Teladoc (NYSE TDOC) Stock Chart for Tuesday, April, 24, 2018
Loading chart…
